Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Pending LLM rewrite. Source: FDA_DRUG D-0573-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0570-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0579-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0576-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0575-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0558-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0557-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0568-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0566-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0599-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0551-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0550-2026.
Zydus Pharmaceuticals is recalling Erythromycin Tablets, 250 mg, nationwide because certain lots contain N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit due to CGMP deviations.
UCB Biosciences is recalling CIMZIA (certolizumab pegol) prefilled syringes nationwide because of a lack of assurance of sterility. Affected lots are distributed across the US.
Zydus Pharmaceuticals is recalling erythromycin 500 mg tablets nationwide due to the presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit, resulting from manufacturing deviations.
Safecor Health, LLC is recalling Atomoxetine HCl 10 mg capsules because some units are incorrectly labeled as 10 mg when they actually contain 25 mg. Patients taking the mislabeled product may receive an incorrect dose.
Wisconsin Pharmacal Company is recalling MG217 Multi-Symptom Treatment Cream & Skin Protectant due to confirmed presence of Staphylococcus aureus contamination. Affected units are 6 oz tubes with Lot #1024088, expiring 11/30/2026, distributed nationwide and in the Bahamas.
Lupin Pharmaceuticals is recalling Liraglutide Injection due to the presence of white thread-like structures (particulate matter) found in cartridges. The recall affects 217,621 pen injectors distributed nationwide.
Golden State Medical Supply Inc. is recalling Primidone 50 mg tablets due to cross-contamination of the active pharmaceutical ingredient with trace amounts of Acemetacin API. The recall affects 8,526 bottles distributed nationwide.
IntegraDose Compounding Services LLC is recalling fentanyl citrate sterile injection (2,500 mcg/50mL) distributed nationwide due to subpotent drug content. The voluntary recall affects 376 cassettes with lot number 20260310FEN-1, expiration date 09/06/2026.
Safecor Health is recalling a vitamin and mineral dietary supplement oral liquid due to the presence of black particles in the liquid. Affected lots were distributed in Ohio.
Haleon is recalling Gas-X Simethicone 125 mg softgels due to incomplete inactive ingredient information on carton labeling.
ANI Pharmaceuticals is recalling Estradiol Gel 0.1% (Lot M251109) distributed nationwide because some packets were found to be either empty or partially full.
Amerisource Health Services LLC is recalling Primidone Tablets 50 mg due to cross-contamination of the active ingredient with trace amounts of Acemetacin API. The recall affects 225,000 tablets distributed nationwide.
Lannett Company Inc. is recalling Primidone 250mg tablets nationwide due to cross-contamination with trace amounts of Acemetacin in the active pharmaceutical ingredient. The recall affects 44,865 bottles distributed across the USA.